Didn't We Use to Sell an Antidepressant named Brintellix/

[Anonymous]

Now what was the name of the antidepressant we used to sell with Lundbeck? It was Brin something or other wasn't it?

 

[Anonymous]

and your point is?

 

[Anonymous]

Takeda is not committed to Brintellix, period. Hell, our copay card is nowhere as good as the competition. This could be easily changed. No new data. No new managed car coverage. No new nothing. It's as good as it gets with this drug. It has maxed out in less than a year.

 

[Anonymous]

Its as good as it gets at Takeda whats next nothing?

 

[Anonymous]

Please tell, what is Takeda committed to?

 

[Anonymous]

Use? Or used? Wow.....must be Takeda legacy

 

[Anonymous]

Use? Or used? Wow.....must be Takeda legacy

The point is, the drug has hit it's peak already. Nobody is motivated, in either company, because the sales goals are so far out of sight, that why bother. We are stuck with an inferior copay card and below par managed care coverage. Can you say flat line?

 

[Anonymous]

Another Tapper run launch....enuf said

 

[Anonymous]

Another Tapper run launch....enuf said

Where is The We Can't Sell Savings Card~said every loser douche Takeda Legacy rep who has never ever executed a successful launch

 

[Anonymous]

Where is The We Can't Sell Savings Card~said every loser douche Takeda Legacy rep who has never ever executed a successful launch

f u Tapper Twat

 

[Anonymous]

Where is The We Can't Sell Savings Card~said every loser douche Takeda Legacy rep who has never ever executed a successful launch

The field executes the strategy from the home office. The home office is run by Tappers (and has been for years). As the man said-enuf said.

 

[Anonymous]

The field executes the strategy from the home office. The home office is run by Tappers (and has been for years). As the man said-enuf said.

Both teams have been led by these executives, it is the Takeda Legacy group that always makes excuses for not getting it done.

Rozerem the Reeeeeeemix

 

[Anonymous]

Are we supposed to still be selling this drug? I mean, really?

 

[Anonymous]

Brin what?

 

[Anonymous]

The point is, the drug has hit it's peak already. Nobody is motivated, in either company, because the sales goals are so far out of sight, that why bother. We are stuck with an inferior copay card and below par managed care coverage. Can you say flat line?

Sums it up nicely.

 

[Anonymous]

To answer the OP's question, no, we didn't. And there in lies the problem.

 

[Anonymous]

Now what was the name of the antidepressant we used to sell with Lundbeck? It was Brin something or other wasn't it?

Why yes, I think we used to sell a drug called Brin something or other!

 

[Anonymous]

It IS DATA and STUDIES; where are the cognitive studies? THAT IS KEY?

Cymbalta ran with pain management and won large. We need a hook folks.

 

[Anonymous]

How can we even use a study? What happens hen the doctor asks "aren't you from the company that deletes it's bad data? How do you have the nerve to say this new study is true?

YOU CAN'T!

FUCKING LIARS!!!